CYTOSORBENTS CORPORATION (CTSO) Shareholders’ equity 2016–2025
CYTOSORBENTS CORPORATION (CTSO) shareholders’ equity at each fiscal year-end, per SEC filings.
$5.9MFY2025 · since FY2016: $1.3M → $5.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $5.9M | -46.9% |
| FY2024 | $11.1M | -52.7% |
| FY2023 | $23.5M | -33.6% |
| FY2022 | $35.4M | -43.5% |
| FY2021 | $62.6M | -21.0% |
| FY2020 | $79.2M | +2217.6% |
| FY2019 | $3.4M | -79.8% |
| FY2018 | $16.9M | +65.0% |
| FY2017 | $10.3M | +667.3% |
| FY2016 | $1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice